Additionally, patients with anti-TIF1 autoantibodies were at an increased risk of CAM (OR 4.67 95% CI 2.86–7.63) and cancer (ever) (OR 4.21 95% CI 2.69–6.61). The gene discussed is TRIM24; the disease is cancer.